Hyperuricaemia and Dementia


Dementia is found among people with Hyperuricaemia, especially for people who are male, 60+ old.

The study analyzes which people have Dementia with Hyperuricaemia. It is created by eHealthMe based on reports of 25 people who have Hyperuricaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

25 people who have Hyperuricaemia and Dementia are studied.

What is Hyperuricaemia?

Hyperuricaemia (level of uric acid in the blood that is abnormally high) is found to be associated with 1,215 drugs and 764 conditions by eHealthMe.

What is Dementia?

Dementia (madness) is found to be associated with 2,414 drugs and 1,724 conditions by eHealthMe.

Number of Dementia in Hyperuricaemia reports submitted per year:

Would you have Dementia when you have Hyperuricaemia?

Gender of people who have Hyperuricaemia and experienced Dementia *:

  • female: 43.48 %
  • male: 56.52 %

Age of people who have Hyperuricaemia and experienced Dementia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 20 people, 80.00%
  2. Diabetes: 11 people, 44.00%
  3. Osteoporosis (bones weak and more likely to break): 10 people, 40.00%
  4. Constipation: 7 people, 28.00%
  5. Primary Myelofibrosis (primary disorder of the bone marrow): 7 people, 28.00%
  6. Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 7 people, 28.00%
  7. High Blood Cholesterol: 5 people, 20.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.00%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 16.00%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 12.00%

Common drugs taken by these people *:

  1. Amlodipine: 10 people, 40.00%
  2. Norvasc: 3 people, 12.00%
  3. Zetia: 2 people, 8.00%
  4. Prednisolone: 2 people, 8.00%
  5. Allopurinol: 2 people, 8.00%
  6. Amitiza: 2 people, 8.00%
  7. Crestor: 2 people, 8.00%
  8. Evista: 2 people, 8.00%
  9. Exelon: 2 people, 8.00%
  10. Kayexalate: 2 people, 8.00%

Common symptoms for these people *:

  1. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 9 people, 36.00%
  2. Anaemia (lack of blood): 8 people, 32.00%
  3. Confusion: 8 people, 32.00%
  4. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 8 people, 32.00%
  5. High Blood Cholesterol: 8 people, 32.00%
  6. Memory Loss: 8 people, 32.00%
  7. Blood Calcium Decreased: 7 people, 28.00%
  8. Blood Creatinine Increased: 7 people, 28.00%
  9. Blood Creatine Phosphokinase Increased: 7 people, 28.00%
  10. Nasopharyngitis (inflammation of the nasopharynx): 7 people, 28.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dementia?

Check whether Dementia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Dementia:

Common drugs associated with Dementia:

All the drugs that are associated with Dementia:

Common conditions associated with Dementia:

All the conditions that are associated with Dementia:

How the study uses the data?

The study is based on Dementia and Hyperuricaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: